Variantyx, a Framingham firm specializing in advanced genomic testing for rare genetic disorders, reproductive health, and precision oncology, has secured $41.5 million in additional funding to advance its rapidly growing global precision oncology business.
/PRNewswire/ Variantyx, a technology-driven precision medicine company providing advanced genomic testing for the rare genetic disorders, reproductive.